Amylin analogues

The present invention relates to amylin analogues and to their use in the treatment or prevention of a variety of diseases, conditions or disorders, including obesity, excess food intake and associated metabolic diseases such as diabetes. The analogues have good physical and chemical stability, good...

Full description

Saved in:
Bibliographic Details
Main Authors Demmer, Oliver, Villadsen, Jesper Sloth, Hamprecht, Dieter Wolfgang, Giehm, Lise, Just, Rasmus, Skarbaliene, Jolanta, Deryabina, Maria Alexandrovna, Munch, Henrik Kofoed, Mathiesen, Jesper Mosolff
Format Patent
LanguageEnglish
Published 21.09.2017
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to amylin analogues and to their use in the treatment or prevention of a variety of diseases, conditions or disorders, including obesity, excess food intake and associated metabolic diseases such as diabetes. The analogues have good physical and chemical stability, good solubility, and a long duration of action, and are well suited for use in the form of a liquid formulation.
Bibliography:Application Number: AU20160232218